Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ploom, now known as Pax Labs, is a technology company that designs and develops vaporizers for tobacco and botanical materials. Founded by Stanford design graduates, the company gained prominence for its innovative approach to heating rather than burning substances, aiming to provide a cleaner alternative to traditional smoking. Their product line includes the Ploom and Pax series of vaporizers, which utilize conduction heating technology to release active ingredients as vapor. While primarily a consumer electronics firm, its products are frequently discussed in the context of harm reduction and nicotine delivery systems within the healthcare and public health sectors. The company's original Ploom brand was eventually sold to Japan Tobacco International (JTI), while the remaining entity rebranded as Pax Labs to focus on its botanical vaporizer line.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ploom.